Discoveries in mitochondria open new field of cancer research
Researchers at Virginia Commonwealth University Massey Cancer Center have revealed novel mechanisms in mitochondria that have implications for cancer as well as many other age-related diseases such as Parkinson’s disease, heart disease and hypertension. This discovery has pioneered the formation of a whole new field within epigenetics research ripe with possibilities of developing future gene therapies to treat cancer and age-associated diseases.
Researcher awarded NCI grant to investigate novel anti-tumor vaccine
Xiang-Yang (Shawn) Wang, Ph.D., was recently awarded a $310,213 grant from the National Cancer Institute to support his research involving large stress proteins (LSPs) in immune regulation and cancer immunotherapy. Wang is a VCU Massey Cancer Center Harrison Scholar, member of the VCU Institute of Molecular Medicine and associate professor of human and molecular genetics at the VCU School of Medicine.
New therapy for blood cancers developed
Clinical researchers at VCU Massey Cancer Center have successfully completed a phase 1 clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a phase 2 clinical trial to test the safety and effectiveness of the new therapy.
Researcher named Fulbright Scholar
Virginia Commonwealth University Massey Cancer Center Senior Analyst J. Brian Cassel, Ph.D., was recently named a Fulbright Scholar by the United States Department of State and the J. William Fulbright Foreign Scholarship Board. Cassel will depart in early 2012 for London, where for six months he will collaborate with researchers at the King's College London Cicely Saunders Institute to measure the economic impact of end-of-life care in the U.K. and U.S.
Gov. McDonnell presents $5 million to Massey to support cancer research
At a celebration event today, Gov. Bob McDonnell ceremonially presented a check representing $5 million in state appropriations for fiscal year 2012 to Virginia Commonwealth University Massey Cancer Center. The funding was approved by the General Assembly this winter when the body accepted the governor's budget amendment to provide the additional resources for the center. The $5 million allocation will help Massey to expand and strengthen its research as it works toward achieving National Cancer Institute (NCI) Comprehensive status, the highest level of distinction for a cancer center. Comprehensive status would make Massey the only facility in Virginia with such a designation, and one of only 40 nationally.